arrow
C

Claire J. Steves

st thomas hospital
H指数:74
被引数:3.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Socio-Demographic Inequalities in COVID-19 Health Care Access and Experiences in the United Kingdom: Intersectional and Mixed-Methods Analyses of Open and Closed Questions in a Prospective Cohort Study

英国COVID-19医疗保健获取和体验中的社会人口不平等:前瞻性队列研究中开放式和封闭式问题的交叉分析和混合方法分析

2026-06-010
OAAI
From Offline to Inline Without Pain: A Practical Framework for Translating Offline MR Reconstructions to Inline Deployment Using the Gadgetron Platform

从离线到在线无障碍:一种利用Gadgetron平台将离线MR重建转换为在线部署的实用框架

2026-04-010
OAAI
A streamlined CMR-derived machine-learning model for estimating cardiovascular biological age: development and validation in the UK-biobank and multi-ethnic study of atherosclerosis

一种基于CMR的机器学习模型,用于估算心血管生物学年龄:在UK-biobank和动脉粥样硬化多民族研究中的开发与验证

2025-12-040
OAAI
Patient characteristics associated with clinically coded long COVID: an OpenSAFELY study using electronic health records

与临床编码的长期COVID相关的患者特征:一项基于电子健康记录的OpenSAFELY研究

2025-12-010
PRE
Left ventricular geometry, brain architecture, and cognition: an observational study

左心室几何形态、大脑结构和认知:一项观察性研究

2025-10-011
PRE
Correction: Longitudinal association of perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) exposure with lipid traits, in a healthy unselected population

更正: 在健康的未经选择的人群中,全氟辛酸 (PFOA) 和全氟辛烷磺酸 (PFOS) 暴露与脂质特征的纵向关联

2025-07-180
OA
Longitudinal association of perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) exposure with lipid traits, in a healthy unselected population

在健康的未经选择的人群中,全氟辛酸 (PFOA) 和全氟辛烷磺酸 (PFOS) 暴露与脂质性状的纵向关联

2025-04-240
OA
Effect of gut microbiome modulation on muscle function and cognition: the PROMOTe randomised controlled trial (vol 15, 1859, 2024)

肠道微生物组调控对肌肉功能和认知的影响:PROMOTe 随机对照试验(卷 15,1859,2024)

2025-04-100
OA
Metformin and physical performance in older people with probable sarcopenia and physical prefrailty or frailty in England (MET-PREVENT): a double-blind, randomised, placebo-controlled trial

二甲双胍和身体表现:英格兰可能发生肌肉减少症和身体前虚弱或虚弱老年人的研究(MET-PREVENT):一项双盲、随机、安慰剂对照试验

2025-03-011
OAAI
Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trial

缓激肽受体2 (BDKRB2) 变体与身体表现和肌肉质量的关联: LACE肌少症试验的发现

2024-08-020
OAAI